Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Olaparib
Peripheral Primitive Neuroectodermal Tumor
National Cancer Institute (NCI)P2CCC (53)
Olaparib
Grade II Glioma
National Cancer Institute (NCI)P2CCC (53)
Olaparib
Grade III Glioma
National Cancer Institute (NCI)P2CCC (53)
Olutasidenib
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)P2CCC (53)
Olutasidenib
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Urinary Bladder Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Cervical Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Colon Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Carcinoma Of Esophagus
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Gastric Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Head And Neck Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Renal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Lung Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Uterine Corpus Cancer
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Uterine Cancer
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Rectal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Skin Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Osimertinib
Thyroid Gland Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Oxaliplatin
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)P2CCC (53)
Oxodotreotide
Prostate Small Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Oxodotreotide
Von Hippel-Lindau Disease
National Cancer Institute (NCI)P2CCC (53)
Palbociclib
Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Showing 1851 to 1875 of 3,272 assets
PreviousPage 75 of 131Next